Cannabis for Spasticity in Multiple Sclerosis

Summary

The purpose of this study is to learn if the use of inhaled cannabis (marijuana) and oral cannabinoid (dronabinol, Marinol or THC, which is an active ingredient of marijuana) is safe and effective in reducing the symptoms of spasticity and tremor in patients with secondary-progressive or primary progressive multiple sclerosis.

Timeline

Start

2003-03

Primary completion

—

Completion

2006-01

Outcome

Outcome not reported

Stopped (Enrollment): “Discontinued due to non-enrollment.”

Drugs

Indications